Covid-19 Clinical Trials

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
Covid-19 Clinical Trials
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Covid-19 Clinical Trials

The Stage of Covid-19 Clinical Trials in Latin America 2023 – Full Service CRO

In 2023, Latin America is still grappling with the COVID-19 pandemic. The region has seen a surge in cases and deaths, with healthcare systems overwhelmed and struggling to cope. However, there is hope on the horizon in the form of COVID-19 clinical trials that are taking place across the region.

Clinical trials are the process by which new drugs, vaccines, and medical treatments are tested for safety and efficacy before they can be approved for use by regulatory bodies such as the US Food and Drug Administration (FDA) or the European Medicines Agency (EMA).

In the case of COVID-19, clinical trials have been crucial in the search for effective treatments and vaccines.

Here’s a closer look at the stage of COVID-19 clinical trials in Latin America in 2023.

Vaccine Trials

Vaccines are the most effective way to prevent the spread of infectious diseases. Several COVID-19 vaccines have already been approved for use in many countries around the world, including Latin America. However, vaccine trials continue in the region to develop new vaccines or to test the effectiveness of existing ones.

In Mexico, the National Autonomous University of Mexico (UNAM) is currently testing a COVID-19 vaccine developed by its scientists. The vaccine is an mRNA vaccine similar to those developed by Pfizer-BioNTech and Moderna. The vaccine has shown promising results in preclinical trials, and the clinical trial will involve over 2,000 participants.

In Brazil, the Butantan Institute is conducting clinical trials for a COVID-19 vaccine developed by China’s Sinovac. The vaccine, called CoronaVac, has already been approved for emergency use in Brazil, but the clinical trial aims to test the vaccine’s efficacy against new COVID-19 variants. The trial will involve over 10,000 participants.

Argentina is also conducting COVID-19 vaccine trials. The country is testing the Russian-made Sputnik V vaccine, which has already been approved for use in Russia and other countries. The clinical trial aims to test the vaccine’s effectiveness against new variants of the virus.

Treatment Trials

There are currently no approved treatments for COVID-19, but several drugs are being tested in clinical trials in Latin America.

In Peru, a clinical trial is underway to test the effectiveness of ivermectin in treating COVID-19. Ivermectin is an anti-parasitic drug that has shown some promise in treating COVID-19, but its effectiveness is still being studied. The trial will involve over 1,500 participants.

In Brazil, the Oswaldo Cruz Foundation is conducting a clinical trial to test the effectiveness of the drug nitazoxanide in treating COVID-19. Nitazoxanide is an anti-parasitic drug that has shown some potential in treating COVID-19, but more research is needed to confirm its effectiveness. The trial will involve over 600 participants.

Covid-19 Clinical Trials

Covid-19 Clinical Trials

Challenges and Opportunities

The COVID-19 pandemic has highlighted the importance of clinical trials in developing effective treatments and vaccines. However, conducting clinical trials during a pandemic presents several challenges.

One of the biggest challenges is recruiting participants. With healthcare systems overwhelmed and people hesitant to participate in clinical trials due to concerns about the virus, recruiting participants can be difficult. Additionally, clinical trial sites may be overwhelmed with COVID-19 patients, making it difficult to conduct trials.

Another challenge is ensuring the safety of participants. COVID-19 clinical trials involve exposing participants to the virus, which can be dangerous. It is crucial to ensure that clinical trial protocols are followed and that participants are monitored closely for any adverse reactions.

Despite these challenges, COVID-19 clinical trials in Latin America also present opportunities. The trials provide an opportunity to develop treatments and vaccines that are effective against new COVID-19 variants. Additionally, the trials can help build capacity in the región for conducting clinical trials and research, which can benefit the region in the long term.

The COVID-19 pandemic has also highlighted the importance of international collaboration in developing treatments and vaccines. Several COVID-19 clinical trials in Latin America are being conducted in collaboration with international partners, such as the World Health Organization (WHO) and the Coalition for Epidemic Preparedness Innovations (CEPI).

This collaboration can help ensure that the most promising treatments and vaccines are developed and made available to the people who need them most.

Another opportunity presented by COVID-19 clinical trials in Latin America is the potential for innovation. The pandemic has forced healthcare systems to adapt and find new solutions to the challenges they face. Clinical trials can provide an opportunity for scientists and researchers to innovate and develop new approaches to treating and preventing infectious diseases.

In conclusion, COVID-19 clinical trials in Latin America are crucial in the search for effective treatments and vaccines. While the region continues to struggle with the pandemic, clinical trials offer hope for a brighter future. By collaborating with international partners, building capacity, and innovating, Latin America can play a key role in the global fight against COVID-19 and other infectious diseases.

Source: The Institute for Science & Policy

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Covid-19 Clinical Trials

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Covid-19 Clinical Trials

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Covid-19 Clinical Trials

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Covid-19 Clinical Trials

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Covid-19 Clinical Trials

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Covid-19 Clinical Trials

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Covid-19 Clinical Trials

The Cohortias Team

Covid-19 Clinical Trials

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Covid-19 Clinical Trials

Network & Partnerships